EDC4 and genital herpes: Our overall conclusion based on studies in mice is that there is no advantage to adding gC1, gD1, or gE1 to the tri-HSV-2 vaccine for preventing HSV-1 genital herpes, particularly because adding HSV-1 mRNA immunogens may require lowering the concentrations of HSV-2 immunogens to avoid toxicity [29].